卒中新型危险因素的研究进展

摘要/Abstract

摘要：

卒中危险因素有高血压、糖尿病、血脂异常、无症状性颈动脉狭窄、冠状动脉粥样硬化性心脏病、高同型半胱氨酸血症、短暂性脑缺血发作、心房颤动、吸烟、酗酒、肥胖、年龄等。这些危险因素已经得到证实并发表在国内外杂志上。为了使广大学者认识更多尚未公认而又具有潜在性风险的危险因素，本文主要对近期提出的危险因素如冠状动脉钙化、脂联素、高尿酸血症、尿微量白蛋白、体温、氧化三甲胺等的最新研究进展进行综述。

文章导读： 通过介绍卒中新型危险因素的研究进展，有望促进临床上尝试多途径干预卒中，将给卒中的预防
和预后带来益处。

关键词: 卒中; 新型危险因素; 研究进展

Abstract:

The classical risk factors of stroke are hypertension, diabetes mellitus, dyslipidemia, asymptomatic carotid artery stenosis, coronary artery disease, hyperhomocysteinemia, transient ischemic attack (TIA), atrial fibrillation, smoking, drinking, obesity, and age, etc. Those risk factors have been researched a lot, confirmed repeatedly, and published in the journals both at home and abroad. In order to make the general scholars know more about the potential risk factors which have not been recognized, this article mainly reviews the recent studies of the risk factors of stroke such as coronary artery calcification, adiponectin, hyperuricemia, urinary microalbumin, temperature and trimetlylamine oxide.

Key words: Stroke; Risk factors; Research

康劲，唐立鸿，郭洪波. 卒中新型危险因素的研究进展[J]. 中国卒中杂志, 2014, 9(04): 345-349.

KANG Jin, TANG Li-Hong, GUO Hong-Bo.. Research Progress of Stroke Risk Factors[J]. Chinese Journal of Stroke, 2014, 9(04): 345-349.

参考文献

1 中华医学会神经病学分会脑血管病学组急性缺血性

脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治

指南2010[J]. 中华神经科杂志, 2010, 43:146-153.

2 Go AS, Mozaffarian D, Roger VL, et al. Executive

summary:heart disease and stroke statistics--2013

u p d a t e : a r e p o r t f r om t h e Ame r i c a n He a r t

Association[J]. Circulation, 2013, 127:143-152.

3 Rennenberg RJ, Kessels AG, Schurgers LJ, et al.

Vascular calcifications as a marker of increased

cardiovascular risk:a meta-analysis[J]. Vasc Health

Risk Manag, 2009, 5:185-197.

4 Sekikawa A, Curb JD, Edmundowicz D, et al.

Coronary artery calcification by computed tomography

in epidemiologic research and cardiovascular disease

prevention[J]. J Epidemiol, 2012, 22:188-198.

5 Kim BJ, Choi SY, Lee SH, et al. Advanced coronary

artery calcification is associated with ischemic

stroke[J]. Cerebrovasc Dis, 2010, 30:93-100.

6 Hermann DM, Gronewold J, Lehmann N, et al.

Coronary artery calcification is an independent stroke

predictor in the general population[J]. Stroke, 2013,

44:1008-1013.

7 Kanhai DA, Kranendonk ME, Uiterwaal CS, et al.

Adiponectin and incident coronary heart disease and

stroke. A systematic review and meta-analysis of

prospective studies[J]. Obes Rev, 2013, 14:555-567.

8 刘世英, 王丽荣, 丁兆日. 进展性脑卒中患者血清脂

联素水平检测及其意义[J]. 中国老年学杂志, 2013,

33:4262-4263.

9 梁江红. 脑梗死患者血清脂联素水平变化及临床意义

[J]. 实用医学杂志, 2012, 28:3880-3882.

10 Arregui M, Buijsse B, Fritsche A, et al. Adiponectin

and risk of stroke:prospective study and metaanalysis[

J]. Stroke, 2013, 45:10-17.

11 周绍霞, 刘煜敏. 脂联素与缺血性卒中[J]. 国际脑血管

病杂志, 2012, 20:787-791.

12 Kim BJ, Choi SY, Lee SH, et al. Hyperuricemia

and risk of stroke:a systematic review and metaanalysis[

J]. Arthritis Rheum, 2009, 61:885-892.

13 Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is

a risk factor for myocardial infarction and stroke:the

Rotterdam study[J]. Stroke, 2006, 37:1503-1507.

14 Chamorro A, Obach V, Cervera A, et al. Prognostic

significance of uric acid serum concentration in

patients with acute ischemic stroke[J]. Stroke, 2002,

33:1048-1052.

15 Amaro S, Soy D, Obach V, et al. A pilot study of

dual treatment with recombinant tissue plasminogen

activator and uric acid in acute ischemic stroke[J].

Stroke, 2007, 38:2173-2175.

16 中国高血压防治指南修订委员会. 中国高血压防治指

南2010[J]. 中华心血管病杂志, 2011, 39:579-616.

17 Da s P, Bhuiyan MM, Mia BA, et al. Ur ina r y

microalbumin as a risk factor for ischaemic stroke[J].

Mymensingh Med J, 2012, 21:709-714.

18 Lee M, Saver JL, Chang KH, et al. Impact of

mic roalbuminu r ia on incident st roke:a met aanalysis[

J]. Stroke, 2010, 41:2625-2631.

19 Nidhinandana S, Chaisinanunkul N. The association

between r isk factor s for ischemic st roke and

microalbuminuria[J]. J Med Assoc Thai, 2010, 93

Suppl 6:S55-S59.

20 Cho BH, Kim JT, Chang J, et al. Early clinical

implications of microalbuminuria in patients with

acute ischaemic stroke[J]. Postgrad Med J, 2012,

88:632-638.

21 Gumb i n g e r C, Sy k o r a M, Di e d l e r J , e t a l .

Microalbuminuria:a potential prognostic marker for

acute stroke[J]. Nervenarzt, 2012, 83:1357-1360.

22 Ovbiagele B. Microalbuminuria:risk factor and potential therapeutic target for stroke?[J]. J Neurol Sci,

2008, 271(1-2):21-28.

23 刘丽萍, 王拥军. 体温与卒中的关系[J]. 国外医学(脑

血管疾病分册), 2004, 12:267-270.

24 Prasad K, Krishnan PR. Fever is associated with

doubling of odds of short-term mortality in ischemic

stroke:an updated meta-analysis[J]. Acta Neurol

Scand, 2010, 122:404-408.

25 Tiainen M, Meretoja A, Strbian D, et al. Body

temperature, blood infection parameters, and outcome

of thrombolysis-treated ischemic stroke patients[J].

Int J Stroke, 2013, 8:632-638.

26 Kvistad CE, Thomassen L, Waje-Andreassen U, et

al. Low body temperature associated with severe

ischemic stroke within 6 hours of onset:The Bergen

NORSTROKE Study[J]. Vasc Health Risk Manag,

2012, 8:333-338.

27 Boysen G, Christensen H. Stroke severity determines

body temperature in acute stroke[J]. Stroke, 2001,

32:413-417.

28 肖婷婷, 余丹. 亚低温治疗缺血性脑卒中的机制探讨

[J]. 中华老年心脑血管病杂志, 2013, 15:445-446.

29 de Ridder IR, de Jong FJ, den Hertog HM, et al.

Paracetamol (Acetaminophen) in stroke 2 (PAIS

2):Protocol for a randomized, placebo-controlled,

double-blind clinical trial to assess the effect of highdose

paracetamol on functional outcome in patients

with acute stroke and a body temperature of 36.5

degrees C or above[J]. Int J Stroke, 2013.

30 Tang WH, Wang Z, Levison BS, et al. Intestinal

microbial metabolism of phosphatidylcholine and

cardiovascular risk[J]. N Engl J Med, 2013, 368:1575-

1584.

31 Koeth RA, Wang Z, Levison BS, et al. Intestinal

microbiota metabolism of L-carnitine, a nutrient in

red meat, promotes atherosclerosis[J]. Nat Med, 2013,

19:576-585.

32 Zhao D, Liu J, Wang W, et al. Epidemiological

t ransition of st roke in China:twenty-one-year

observational study from the Sino-MONICA-Beijing

Project[J]. Stroke, 2008, 39:1668-1674.

[1]	鲁燕, 杨保荣, 黄向萍, 杨冠桂, 陈圣文, 李建荣, 曾小明. 县级医院急性缺血性卒中超时间窗经MRI筛选溶栓的病例对照研究 [J]. 中国卒中杂志, 2022, 17(12): 1321-1326.
[2]	楚悦琪, 周凯云, 王田燕, 王炯彬, 李真. 卒中后吞咽障碍应用耳穴压豆治疗效果的meta分析 [J]. 中国卒中杂志, 2022, 17(12): 1327-1334.
[3]	周甜甜, 苏文杰, 连松勇, 林友聪. 丰富环境对卒中后血管性痴呆患者认知功能的影响 [J]. 中国卒中杂志, 2022, 17(12): 1343-1349.
[4]	吴娱倩, 张玉梅, 范小伟, 王安心, 逄文斌. 运动想象-动觉治疗对缺血性卒中患者手功能康复效果的研究[J]. 中国卒中杂志, 2022, 17(12): 1366-1371.
[5]	蒋林, 李靖. 基于知识图谱分析人工智能用于卒中研究的现状及趋势 [J]. 中国卒中杂志, 2022, 17(12): 1372-1380.
[6]	梁潇, 钱海兵. 水通道蛋白4与卒中后认知障碍的关系研究进展[J]. 中国卒中杂志, 2022, 17(12): 1385-1390.
[7]	吴晓莉, 刘丽旭. 肥胖对卒中预后的影响[J]. 中国卒中杂志, 2022, 17(12): 1391-1395.
[8]	伊珞, 周宏宇, 仇鑫, 李子孝, 王拥军. 动脉粥样硬化性疾病的DNA甲基化改变[J]. 中国卒中杂志, 2022, 17(11): 1163-1170.
[9]	王誉博, 李子孝, 王拥军. 表观遗传学与缺血性卒中后氧化应激的相关性研究进展[J]. 中国卒中杂志, 2022, 17(11): 1171-1177.
[10]	闫然, 闵妍, 全柯华, 李子孝. 脑源性神经营养因子和血清素再摄取转运体编码基因甲基化与卒中预后的关系[J]. 中国卒中杂志, 2022, 17(11): 1178-1182.
[11]	崔凌云, 仇鑫, 周宏宇, 李子孝, 王拥军. DNA甲基化与2型糖尿病的相关性研究进展[J]. 中国卒中杂志, 2022, 17(11): 1183-1188.
[12]	邓宇含, 刘爽, 王子尧, 汪雨欣, 刘宝花. 基于结构化数据和机器学习模型预测普通人群卒中发病风险的系统评价和meta分析 [J]. 中国卒中杂志, 2022, 17(11): 1189-1197.
[13]	刘光亮, 韩凯月, 苏文龙, 张皓. 不同强度有氧踏车训练对不同病程缺血性卒中患者运动和心肺适能的影响 [J]. 中国卒中杂志, 2022, 17(11): 1203-1208.
[14]	孙默一, 张玉梅, 刘然, 赵依双. 不同时间康复介入对卒中患者运动功能的影响 [J]. 中国卒中杂志, 2022, 17(11): 1209-1215.
[15]	胡红梅, 杨磊, 于玲, 秦伟, 白明悦, 胡文立. 急性单发小脑小梗死的临床特征 [J]. 中国卒中杂志, 2022, 17(11): 1221-1226.